TP73 and triple-negative breast carcinoma: This inhibitory association was detected also in cell lines derived from triple negative breast cancers (TNBC, lacking estrogen and progesterone receptors and Her2 amplification), where treatment with cisplatin can activate the c-Abl/TA-p73 axis and induce apoptosis.